NantHealth Priced, Nasdaq: NH

Provides healthcare data solutions and will launch new cancer diagnostic.

Industry: Health Care

Latest Trade: $2.93 0.00 (0.0%)

First Day Return: +32.8%

Return from IPO: -79.1%

Industry: Health Care

We are a leading next-generation, evidence-based, personalized healthcare company enabling improved patient outcomes and more effective treatment decisions for critical illnesses. Our unique systems-based approach to personalized healthcare applies novel diagnostics tailored to the specific molecular profiles of patient tissues and integrates this molecular data in a clinical setting with large-scale, real-time biometric signal and phenotypic data to track patient outcomes and deliver precision medicine. For nearly a decade, we have developed an adaptive learning system, CLINICS, which includes our unique software, middleware and hardware systems infrastructure that collects, indexes, analyzes and interprets billions of molecular, clinical, operational and financial data points derived from novel and traditional sources, continuously improves decision-making and further optimizes our clinical pathways and decision algorithms over time. As a pioneer in the era of big data and augmented intelligence, we believe we are uniquely positioned to benefit from multiple significant market opportunities as healthcare providers and payors transition from fee-for-service to value-based reimbursement models and accelerate their pursuit of evidence-based clinical practice.
more less
IPO News for NantHealth
more
IPO Data
IPO File Date 05/06/2016
Offer Price $14.00
Price Range $12.50 - $15.50
Offer Shares (mm) 6.5
Deal Size ($mm) $91
IPO Data
IPO Date 06/01/2016
Offer Price $14.00
Price Range $12.50 - $15.50
Offer Shares (mm) 6.5
Deal Size ($mm) $91
Underwriters
more
Company Data
Headquarters Culver City, CA
Founded 2007
Employees 864
Website www.nanthealth.com